Double maintains 1 strategies that include AZN - AstraZeneca PLC
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NVS | 62.53% | $220.90B | +10.93% | 3.45% |
GSK | 59.08% | $80.53B | -3.00% | 4.08% |
TAK | 48.82% | $46.86B | +17.52% | 2.19% |
GMAB | 48.72% | $13.54B | -14.61% | 0.00% |
LIN | 46.83% | $216.96B | +4.75% | 1.25% |
PFE | 46.32% | $136.45B | -12.44% | 7.13% |
SNY | 45.61% | $117.49B | +2.12% | 4.59% |
LLY | 45.44% | $749.89B | -11.24% | 0.71% |
ECL | 44.55% | $74.09B | +7.42% | 1.18% |
HLN | 42.55% | $47.24B | +24.11% | 1.69% |
MRK | 42.05% | $196.56B | -38.84% | 5.13% |
YUM | 41.46% | $38.91B | +3.37% | 1.99% |
UL | 40.62% | $152.70B | +10.75% | 3.12% |
BIIB | 40.39% | $18.54B | -43.41% | 0.00% |
TMO | 39.91% | $147.32B | -31.43% | 0.42% |
SYK | 39.65% | $142.69B | +7.08% | 0.88% |
WDI | 39.59% | - | - | 12.01% |
IQV | 39.37% | $26.66B | -27.59% | 0.00% |
DTE | 39.16% | $27.39B | +19.35% | 4.02% |
MFA | 39.14% | $964.94M | -14.16% | 15.03% |
Current Value
$71.121 Year Return
Current Value
$71.121 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GBIL | 0.15% | $6.18B | 0.12% |
AGZD | 0.17% | $111.95M | 0.23% |
DBC | -0.19% | $1.26B | 0.87% |
CORN | -0.22% | $47.84M | 0.2% |
XBIL | -0.24% | $795.12M | 0.15% |
IVOL | 0.57% | $346.82M | 1.02% |
TFLO | 0.68% | $6.90B | 0.15% |
XHLF | 0.78% | $1.66B | 0.03% |
BILZ | -0.83% | $840.57M | 0.14% |
EZBC | 1.02% | $536.03M | 0.29% |
BOXX | 1.05% | $6.64B | 0.19% |
FBTC | 1.06% | $20.74B | 0.25% |
BTCW | 1.10% | $162.76M | 0.3% |
BITO | 1.11% | $2.44B | 0.95% |
ARKB | 1.11% | $4.85B | 0.21% |
BRRR | 1.12% | $614.22M | 0.25% |
GBTC | 1.13% | $19.49B | 1.5% |
BITB | 1.16% | $4.06B | 0.2% |
PDBC | 1.17% | $4.54B | 0.59% |
HODL | 1.24% | $1.63B | 0.25% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PPH | 69.82% | $606.82M | 0.36% |
IXJ | 64.27% | $3.82B | 0.41% |
EWL | 58.96% | $1.32B | 0.5% |
EWU | 56.57% | $3.10B | 0.5% |
IHE | 55.88% | $574.16M | 0.39% |
FLGB | 55.19% | $801.60M | 0.09% |
IYH | 54.95% | $2.77B | 0.39% |
XLV | 54.53% | $34.81B | 0.09% |
VHT | 54.11% | $15.53B | 0.09% |
IDHQ | 53.51% | $460.32M | 0.29% |
FHLC | 53.38% | $2.47B | 0.084% |
FICS | 52.53% | $224.12M | 0.7% |
EFAV | 52.41% | $5.51B | 0.2% |
IEV | 51.94% | $2.26B | 0.61% |
BBEU | 51.81% | $4.61B | 0.09% |
QEFA | 51.64% | $863.34M | 0.3% |
ACWV | 51.55% | $3.37B | 0.2% |
SPEU | 51.43% | $733.10M | 0.07% |
HDEF | 51.42% | $2.06B | 0.09% |
KXI | 51.11% | $856.33M | 0.41% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -27.89% | $196.95M | 0.85% |
TAIL | -27.71% | $104.04M | 0.59% |
USDU | -17.22% | $163.79M | 0.5% |
CLIP | -16.33% | $1.50B | 0.07% |
UUP | -15.62% | $156.34M | 0.77% |
TPMN | -14.14% | $30.86M | 0.65% |
FTSD | -9.47% | $228.45M | 0.25% |
UGA | -8.33% | $77.18M | 0.97% |
CANE | -6.62% | $9.88M | 0.29% |
KCCA | -5.93% | $98.85M | 0.87% |
TBLL | -5.47% | $2.24B | 0.08% |
DBE | -5.31% | $52.31M | 0.77% |
WEAT | -3.93% | $121.36M | 0.28% |
BNO | -3.74% | $97.13M | 1% |
USL | -3.50% | $43.35M | 0.85% |
BTAL | -3.28% | $296.94M | 1.43% |
USO | -3.28% | $1.20B | 0.6% |
SGOV | -2.94% | $48.91B | 0.09% |
OILK | -2.51% | $74.96M | 0.69% |
SOYB | -1.29% | $26.17M | 0.22% |
Yahoo
Pharmaceutical stocks, including Pfizer (PFE), Johnson & Johnson (JNJ), Abbvie (ABBV), Novo Nordisk (NVO), and Astrazeneca (AZN), are falling after President Trump said tariffs on the industry are coming "very soon." Chris Meekins, managing director and Washington health policy research analyst at Raymond James, joins Market Domination to discuss potential tariffs and explain how President Trump's tax bill could affect the pharmaceutical industry. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.
SeekingAlpha
Madison International Equity ADR SMA Q1 2025 Investment Strategy Letter
SeekingAlpha
Verve: Eli Lilly Acquisition Based On One-Time GalNAc PCSK9 Gene Editing Program
Yahoo
Astrazeneca (AZN) concluded the recent trading session at $73.55, signifying a -1.17% move from its prior day's close.
Yahoo
Surovatamig shows promise, but needs to outperform established therapies such as Blincyto and Aucatzyl.
Yahoo
AstraZeneca (NASDAQ:AZN) is one of the 8 Best Inexpensive Stocks to Buy Right Now. On June 9, the first patient was dosed by AstraZeneca in the DESTINY-Endometrial01 phase 3 trial. AstraZeneca is jointly developing and commercializing ENHERTU, which is the drug being evaluated in the DESTINY-Endometrial01 phase 3 trial, with Daiichi Sankyo under a global […]
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BMBL | -0.03% | $540.21M | -48.12% | 0.00% |
ORN | 0.03% | $344.52M | -14.69% | 0.00% |
PACB | -0.05% | $390.11M | -20.97% | 0.00% |
BEEM | 0.06% | $22.21M | -72.73% | 0.00% |
JBI | 0.12% | $1.10B | -40.59% | 0.00% |
GIII | -0.13% | $934.54M | -21.36% | 0.00% |
WS | -0.13% | $1.30B | -16.13% | 2.49% |
DDD | -0.13% | $255.09M | -46.88% | 0.00% |
PARAA | -0.14% | $15.37B | +33.96% | 1.10% |
BRY | -0.16% | $254.52M | -46.93% | 7.85% |
GME | 0.20% | $10.28B | -6.92% | 0.00% |
SPWH | 0.23% | $144.84M | +46.51% | 0.00% |
GABC | 0.26% | $1.38B | +11.90% | 3.05% |
VHC | -0.30% | $36.03M | +76.35% | 0.00% |
GRND | -0.32% | $4.51B | +132.06% | 0.00% |
BPT | 0.33% | $15.09M | -70.99% | 0.00% |
PRIM | -0.33% | $4.05B | +35.91% | 0.37% |
BAND | -0.34% | $420.85M | -6.97% | 0.00% |
MGNI | -0.34% | $2.57B | +36.76% | 0.00% |
HAFC | 0.35% | $681.28M | +46.05% | 4.60% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DFDV | -15.18% | $458.02M | +2,978.39% | 0.00% |
TDUP | -11.75% | $947.16M | +379.64% | 0.00% |
LIND | -11.67% | $595.22M | +51.74% | 0.00% |
ARIS | -10.37% | $844.44M | +81.29% | 1.89% |
GALT | -10.09% | $151.27M | +2.58% | 0.00% |
VMEO | -10.05% | $685.34M | +11.23% | 0.00% |
HUSA | -8.73% | $31.37M | +61.29% | 0.00% |
CNTY | -7.91% | $71.18M | -9.02% | 0.00% |
ALAB | -7.33% | $15.32B | +38.34% | 0.00% |
ACIC | -7.11% | $506.26M | +0.31% | 0.00% |
ALNT | -6.68% | $579.98M | +33.00% | 0.35% |
WTTR | -6.58% | $969.22M | -8.36% | 2.88% |
CCRN | -6.51% | $457.33M | -1.48% | 0.00% |
AGL | -6.41% | $869.30M | -68.84% | 0.00% |
IIIV | -6.39% | $600.84M | +25.33% | 0.00% |
UUU | -6.34% | $7.19M | +94.38% | 0.00% |
QUAD | -6.33% | $265.72M | +7.58% | 4.74% |
LTM | -6.29% | $11.26B | -96.35% | 2.65% |
SIBN | -6.28% | $730.84M | +38.42% | 0.00% |
CYCN | -6.23% | $9.97M | +40.57% | 0.00% |